Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

薬物に関連した心臓毒性

A U Buzdar, S S Legha, G N Hortobagyi

    JAMA
    |May 4, 1979
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).

    Breast cancer research and treatment·2016
    Same author

    Which threshold for ER positivity? a retrospective study based on 9639 patients.

    Annals of oncology : official journal of the European Society for Medical Oncology·2014
    Same author

    Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2013
    Same author

    Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2011
    Same author

    Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2009